- Home
- OPRX vs HLVX Comparison
OPRX vs HLVX Comparison
Compare OPRX & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPRX
- HLVX
- Stock Information
- Founded
- OPRX 2006
- HLVX 2020
- Country
- OPRX United States
- HLVX United States
- Employees
- OPRX N/A
- HLVX N/A
- Industry
- OPRX Business Services
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- OPRX Consumer Discretionary
- HLVX Health Care
- Exchange
- OPRX Nasdaq
- HLVX Nasdaq
- Market Cap
- OPRX 137.6M
- HLVX 83.7M
- IPO Year
- OPRX N/A
- HLVX 2022
- Fundamental
- Price
- OPRX $8.09
- HLVX $1.55
- Analyst Decision
- OPRX Buy
- HLVX Hold
- Analyst Count
- OPRX 8
- HLVX 5
- Target Price
- OPRX $9.06
- HLVX $2.33
- AVG Volume (30 Days)
- OPRX 515.1K
- HLVX 221.3K
- Earning Date
- OPRX 05-13-2025
- HLVX 05-08-2025
- Dividend Yield
- OPRX N/A
- HLVX N/A
- EPS Growth
- OPRX N/A
- HLVX N/A
- EPS
- OPRX N/A
- HLVX N/A
- Revenue
- OPRX $92,127,000.00
- HLVX N/A
- Revenue This Year
- OPRX $12.12
- HLVX N/A
- Revenue Next Year
- OPRX $10.87
- HLVX N/A
- P/E Ratio
- OPRX N/A
- HLVX N/A
- Revenue Growth
- OPRX 28.81
- HLVX N/A
- 52 Week Low
- OPRX $3.78
- HLVX $1.34
- 52 Week High
- OPRX $14.13
- HLVX $16.31
- Technical
- Relative Strength Index (RSI)
- OPRX 50.73
- HLVX 42.36
- Support Level
- OPRX $6.80
- HLVX $1.34
- Resistance Level
- OPRX $8.32
- HLVX $1.51
- Average True Range (ATR)
- OPRX 0.77
- HLVX 0.10
- MACD
- OPRX -0.19
- HLVX 0.00
- Stochastic Oscillator
- OPRX 29.11
- HLVX 46.15
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.